Cargando…
Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
BACKGROUND: Bisphosphonates are common first line medications used for the management of benign bone disease. One of the most devastating complications associated with bisphosphonate use is osteonecrosis of the jaws which may be related to duration of exposure and hence cumulative dose, dental inter...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080357/ https://www.ncbi.nlm.nih.gov/pubmed/21477374 http://dx.doi.org/10.1186/1471-2474-12-71 |